FERRARI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.171
AS - Asia 5.110
EU - Europa 3.431
SA - Sud America 817
AF - Africa 129
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.664
Nazione #
US - Stati Uniti d'America 6.019
VN - Vietnam 1.556
SG - Singapore 1.334
IT - Italia 1.186
CN - Cina 1.047
BR - Brasile 610
HK - Hong Kong 529
DE - Germania 445
RU - Federazione Russa 406
SE - Svezia 203
IE - Irlanda 200
GB - Regno Unito 198
FR - Francia 169
IN - India 130
FI - Finlandia 96
UA - Ucraina 96
CA - Canada 86
BD - Bangladesh 78
ID - Indonesia 78
AR - Argentina 76
NL - Olanda 76
KR - Corea 70
AT - Austria 68
DK - Danimarca 64
ES - Italia 60
ZA - Sudafrica 53
MX - Messico 47
TR - Turchia 47
PL - Polonia 43
IQ - Iraq 40
CO - Colombia 37
JP - Giappone 28
PK - Pakistan 27
VE - Venezuela 27
PH - Filippine 25
SA - Arabia Saudita 24
CH - Svizzera 23
EC - Ecuador 22
BE - Belgio 18
CL - Cile 17
CZ - Repubblica Ceca 17
LT - Lituania 16
MA - Marocco 16
UZ - Uzbekistan 16
TN - Tunisia 13
JO - Giordania 12
PY - Paraguay 11
ET - Etiopia 10
IL - Israele 9
IR - Iran 9
KE - Kenya 9
PE - Perù 9
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
AL - Albania 6
GR - Grecia 6
PT - Portogallo 6
RS - Serbia 6
BO - Bolivia 5
MY - Malesia 5
NP - Nepal 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
NO - Norvegia 4
PA - Panama 4
CY - Cipro 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BY - Bielorussia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
SI - Slovenia 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
Totale 15.653
Città #
Ann Arbor 961
Singapore 768
Ashburn 636
Hong Kong 518
Ho Chi Minh City 448
Hanoi 429
Fairfield 408
Milan 400
San Jose 356
Frankfurt am Main 287
Woodbridge 273
Wilmington 248
Dallas 229
Houston 207
Chandler 199
Dublin 192
Seattle 168
New York 166
Cambridge 144
Beijing 142
Hefei 135
Los Angeles 122
Santa Clara 118
Chicago 105
Dearborn 93
Jacksonville 82
Rome 80
Shanghai 70
The Dalles 70
Princeton 69
Dong Ket 64
Seoul 62
Lauterbourg 61
São Paulo 61
Council Bluffs 55
Jakarta 55
Buffalo 52
Vienna 52
Haiphong 50
Helsinki 50
Nanjing 49
Moscow 43
Da Nang 41
Guangzhou 36
Warsaw 35
Lawrence 34
Munich 34
Quận Bình Thạnh 33
Johannesburg 31
London 29
Montreal 29
Biên Hòa 27
Hyderabad 26
Altamura 25
San Diego 25
Hải Dương 24
Denver 23
Orem 23
Poplar 23
Rio de Janeiro 22
Atlanta 21
Nuremberg 21
Zurich 21
Turin 20
Turku 19
Amsterdam 17
Can Tho 17
Ha Long 17
Nanchang 17
Shenyang 17
Thái Nguyên 17
Baghdad 16
Brussels 16
Mexico City 16
Tokyo 16
Toronto 16
Bologna 15
Changsha 15
Dhaka 15
Andover 14
Boardman 14
Brooklyn 14
Kent 14
Tashkent 14
Vũng Tàu 14
Brno 13
Chennai 13
Genoa 13
Lachine 13
Lang Son 13
Lappeenranta 13
Messina 13
Ninh Bình 13
Phoenix 13
Piscataway 13
Zhengzhou 13
Bari 12
Bergamo 12
Caracas 12
Fremont 12
Totale 9.901
Nome #
Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 1.137
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 786
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats 379
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 373
Human neural stem cell transplantation in ALS: Initial results from a phase I trial 327
Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family 314
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 306
Morphological and metabolic changes in microglia exposed to cadmium: Cues on neurotoxic mechanisms 303
A link between genetic disorders and cellular impairment, using human induced pluripotent stem cells to reveal the functional consequences of copy number variations in the central nervous system—a close look at chromosome 15 303
Immortalization of human neural stem cells with the c-myc mutant T58A 297
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis 291
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome 287
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies 282
Mild hypoxia enhances proliferation and multipotency of human neural stem cells 278
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease 263
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 263
Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy 262
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 259
Preliminary data of intracerebroventricular transplantation of human-Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 257
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850) 252
Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage 249
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. 246
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 245
Neural stem cells and human induced pluripotent stem cells to model rare CNS diseases 245
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine 243
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA) 243
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 241
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment 241
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein 241
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation 238
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 238
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment 235
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein 234
Isolation of neural stem cells from neural tissues using the neurosphere technique 233
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease 232
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression 231
Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model 231
Unique expression and localization of aquaporin-4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny 223
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene 219
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization 218
Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smithâ Magenis syndrome 214
Advances in stem cell therapy for amyotrophic lateral sclerosis 213
Exploring the metabolic signature of ALS patients-derived cells 205
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 202
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene 200
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 199
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 199
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 199
Exploring the metabolic signature of Amyotrophic Lateral Sclerosis patients-derived cells 197
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 195
Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies 192
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft 186
Inorganic mercury changes the fate of murine CNS stem cells 184
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation 173
Culturing and Expansion of “Clinical Grade” Neural Stem Cells from the Fetal Human Central Nervous System 164
The stem cells as a potential treatment for neurodegeneration 162
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 155
Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS 154
INTERROGATING ALS SIGNATURE IN HUMAN INDUCED NEURAL STEM CELLS 150
Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate 143
Brain Organoids to Evaluate Cellular Therapies 133
INTERROGATING ALS SIGNATURE IN EARLY NEURAL PROGENITOR CELLS: A DIFFERENT PERSPECTIVE 127
Uncovering primary cilium defects in Joubert Syndrome using iPSCs derived-Neural Stem Cells 114
Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia 79
Totale 16.084
Categoria #
all - tutte 44.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021397 0 0 0 0 0 0 0 0 0 165 58 174
2021/2022607 63 82 75 27 20 40 48 72 30 27 58 65
2022/20231.057 89 269 139 111 93 147 10 51 58 23 39 28
2023/2024909 26 29 56 73 103 188 148 42 68 35 32 109
2024/20253.666 126 195 242 138 183 123 156 110 302 430 251 1.410
2025/20266.218 669 680 547 817 763 357 852 318 588 627 0 0
Totale 16.084